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HOLOPROSENCEPHALY 
 1. Definition and prevalence  
Holoprosencephaly (HPE) is a heterogeneous spectrum of disorders resulting from failure of 
induction and patterning of the prosencephalon leading to various degrees of incomplete 
separation of the cerebral hemispheres, a process normally complete by the fifth week of 
gestation1. 
HPE is the human most common malformation of the brain 2-4 with a prevalence of 1:250 in 
embryos5 and 1:10 000 among live-born infants6-8, given the high abortively rate. 
  
2. Etiology and pathophysiology  
HPE is multifactorial condition involving environmental, teratogenic and genetic causes9, 
commonly acting in the same scenario.  
Maternal diabetes mellitus is one of the most common maternal conditions associated with 
HPE, and infants from diabetic having a 200-fold increase risk for HPE10. The 
pathophysiology for the occurrence of HPE in fetuses from diabetic mothers has not been 
completely elucidated yet but it has been hypothesized to be associated with an interference 
in the glycolytic process and/or an increase production of oxygen reactive species induced by 
fetal hyperglycemia which interferes with the development of neural crest cells. Alcohol, 
retinoic acid and isotretinoin are other commons teratogens associated with an increased risk 
of HPE11. Recently, animal models of maternal hypocholesterolemia have been reported to 
increase the risk of HPE5; likewise, cholesterol-lowering agents (i.e., statins) have been 
associated with HPE, although a clear relationship between statin intake during pregnancy 
and HPE has not been established yet12. 
HPE is common in fetuses with abnormal karyotype and approximately 25-50% of fetuses 
with HPE have abnormal karyotype2,13-15. The most common aneuploidy associated with HPE 
is Trisomy 13, followed by Trisomy 18 and triploidy. Furthermore, HPE can be the results of 
a single gene defect or part of a monogenic syndrome. Autosomal dominant, autosomal 
recessive, and X-linked patterns of inheritance have been described in genetic HPE. 
Furthermore, multiple genetic loci have been such as the Sonic Hedgehog (SHH), ZIC2, 
SIX3, and TG-interacting factor (TGIF) have been described to be associated with induce 
HPE. The most common genetic syndromes associated with HPE are Smith-Lemli-Opitz, 
Pallister-Hall, Meckel and Rubistein-Taybi syndrome16. 
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3. Classification  
HPE encompasses a heterogeneous group of conditions classified according to the severity of 
the failure of prosencephalic development in alobar, semilobar and lobar (Figure 1)17.  
Alobar HPE is a lethal anomaly and the most severe type of HPE, characterized by the 
complete failure of cleavage of the prosencephalon resulting in fused cerebral hemispheres, 
single midline ventricle (called holoventricle), usually having the appearance of a pancake-
like mass, which often communicates posteriorly with a dorsal sac as the result of the 
posterior bulging of the dorsal wall of the ventricle18. The interhemispheric fissure, falx 
cerebri and CC are absent, while basal ganglia, hypothalamic and thalamic nuclei are usually 
not separated, resulting in the absence of the third ventricle19. Olfactory bulbs and tracts are 
absent20. 
In Semilobar HPE, there is no anterior cleavage the prosencephalon which results in 
anteriorly fused cerebral hemispheres which show a certain degree of posterior separation. 
The non-cleaved frontal lobes are usually small, the frontal horns of the lateral ventricle are 
absent, while posterior horns and trigones are present. A small rudimentary interemispheric 
fissure is present in the posterior part of the brain. The CSP and the anterior part of the CC 
are present, but often rudimentary18,21. The deep gray nuclei are incompletely separated, 
usually resulting in a small third ventricle, while the head of caudate nuclei is often non-
separated. The olfactory bulbs are absent or hypoplastic. 
Lobar HPE is the milder phenotypic form of the disease; the cerebral hemispheres are well 
separated in the posterior middle part of the brain while anteriorly the frontal horns are fused 
and have a flat roof that communicates with the third ventricle. CPS is always absent while 
CC may be normal, absent or hypoplastic. Thalami may be fused while olfactory bulbs and 
tracts may be present, although they are usually hypoplastic. 
The middle interhemispheric (MIH) variant or syntelencephaly21,22 is thought to be caused by 
a lack of induction of the dorsal midline and it is characterized by failed separation of the 
posterior frontal and parietal lobes, while the anterior poles of the frontal and occipital lobes 
are well divided. The body of the CC is absent, and the caudate nuclei and thalami are 
incompletely separated. MIH is the only brain anomaly in which the posterior part of the CC 
forms in the absence of its anterior or middle portion23.  
HPE is associated with other CNS and extra-CNS anomalies in about 90% of cases; the type 
and incidence of such anomalies is related to the specific cause of HPE24. The most common 
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anomalies associated with HPE include ACC, microcephaly, facial anomalies, congeniatl 
heart diseases, omphalocele, clubfoot, gastrointestinal and renal anomalies. 
Facial anomalies are common in HPE; the primary defect leading to a failed cleavage of the 
prosencephalon is also responsible for an abnormal differentiation of the facial structures, 
which is directly related to the severity of HPE. The most common facial anomalies 
associated with HPE are cyclopia (single or fused eyes, absent nose, with or without a 
proboscis), etmocephaly (severe hypotelorism associated with the presence of a proboscis 
between the rudimentary eyes), cebocephaly (severe hypotelorism and a single nostril nose), 
median cleft lip and palate and severe hypotelorism25. 
 
4. Prenatal diagnosis  
Prenatal diagnosis of HPE depends upon the severity of the condition. In its most severe 
forms, prenatal diagnosis is possible since the early first trimester of pregnancy at 
approximately 9-10 weeks of gestation on a standard axial view of the brain, while semilobar 
and especially lobar HPE are usually detected in the second trimester of pregnancy but can be 
also overlooked. 
 
On ultrasound, alobar HPE is characterized by an absent interemispheric fissure, lack of 
visualization of two distinct cerebral hemispheres filled by the choroid plexus (“butterfly 
sign”) and presence of a single ventricular cavity communicating with a dorsal sac 26-29 
(Figure 2). Microcephaly is present in 30%30 while abnormal head shape in 80% of cases29. 
Detection of the severe facial anomalies associated with alobar HPE is not always feasible in 
the early first trimester although 3D ultrasound may help in their visualization31-34.  
In semilobar HPE, the interemispheric fissure is absent anteriorly, frontal horns are fused and 
have a flat roof that freely communicates with the third ventricle. Third ventricle is present 
but small while the posterior horns of the lateral ventricles and the posterior part of the 
interemispheric fissure is present posteriorly. The dorsal sac is present in 28% of cases of 
semilobar compared to 92% of alobar HPE35. The hippocampus is seen close to the thalami 
to form the echogenic ambient cistern and could be used in the differential diagnosis from 
alobar HPE.  
Prenatal diagnosis of lobar HPE can be challenging and this condition is commonly not 
diagnosed in the first or early second trimester of pregnancy as its main ultrasound feature, 
an absent CSP, cannot be reliable imagined on ultrasound until 18 weeks of gestation. 
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Sagittal and especially coronal views of the brain are fundamental in order to make an 
accurate diagnosis. Furthermore, absent CSP is not specific of lobar HPE and can be 
associated with other CNS anomalies, such as ACC and SOD.  Interemispheric fissure is 
rudimentary in its anterior part and present posteriorly; frontal horns are rudimentary and 
fused to each other. CC can be present, absent, hypo- or dysplastic. On coronal views, frontal 
lobes appear fused, frontal horns rudimentary with a communication between the lateral 
bodies of the ventricles and columns of the fornix are fused in the midline. On color Doppler, 
the anterior cerebral artery is often pushed anteriorly alongside the frontal bone by an 
abnormal bridge of cortical tissue between the two frontal gyri (snake under the skull sign)36.  
MIH variant of HPE is rarely diagnosed on prenatal ultrasound with only sporadic cases 
reported in the published literature. The anomaly is usually suspected in fetuses referred for 
absent CSP or ACC, especially on coronal views of fetal brain.  On ultrasound, 
interemispheric fissure is present in the anterior frontal but absent in the posterior frontal and 
parietal regions. Frontal horns of the lateral ventricles can be normal or rudimentary but well 
separated. CPS is absent while CC can be totally or partially agenetic or dysplastic. In the 
median in the median part, the ventricles communicated, thalami are fused in about one third 
of cases while basal ganglia are normal. Posteriorly, interemispheric fissure is present and 
occipital lobes separated.  
Ultrasound characteristics of HPE are reported in Table 126-36. 
Differential diagnosis of the different variants of HPE is fundamental as the prognosis may 
significantly vary among the different sub-types of the disease. Alobar HPE is easily 
recognized since the early first trimester of pregnancy while differential diagnosis between 
lobar and semilobar HPE is more challenging as no clear boundary exists between the two 
forms. In semilobar HPE, interemispheric fissure is always absent anteriorly and present 
posteriorly, frontal horns are absent while posterior are present, thalami are generally partially 
fused, and third ventricle is small while a dorsal cyst is generally present. Conversely in lobar 
HPE a rudimentary interemispheric fissure can be present anteriorly and well developed 
posteriorly, third ventricle is generally formed, and thalami separated. The presence of a 
normal cleavage in the proximal anterior part of the brain helps in differentiating MHI variant 
from lobar HPE; furthermore, the hypothalamus and basal ganglia are commonly affected in 
lobar compared to MIH variant of HPE37. 
HPE may be sometimes difficult to differentiate from severe ventriculomegaly and 
hydranencephaly, which, in the most severe cases are characterized by a destruction of the 
midline structure with a large communication between the lateral bodies of the ventricles. 
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The presence of the anterior and posterior interemispheric fissure, communication between 
the lateral ventricles mainly in their median portion, normal cleavage of the thalami, presence 
of a normal corpus callosum, both choroid plexuses in the same side and absence of facial 
anomalies may trigger the diagnosis of severe ventriculomegaly or hydranencephaly. 
Conversely, absent or rudimentary anterior interemispheric fissure, communication between 
the ventricles starting in their anterior portion, lack of cleavage of cerebral hemispheres, 
presence of fused thalami, callosal agenesis, absent choroid plexus and presence of facial 
anomalies are typical of HPE. 
Other differential diagnoses of lobar HPE includes SOD and isolated agenesis of the CSP 34. 
Ultrasound is the primary imaging modality in detecting HPE, especially in its most severe 
forms. Fetal MRI can be useful in the milder forms of HPE which are not easily recognized 
on ultrasound38. MRI can detect fusion of the fornices in lobar HPE and hypoplasia of the 
optic tract in SOD; furthermore, MRI has been shown to be useful in differentiating between 
lobar and MIH variant of HPE37. 
 
5. Prognosis  
Fetuses affected by alobar HPE, especially if associated with other CNS or extra-CNS 
anomalies or abnormal karyotype, have a high risk of miscarriage and intra-uterine death and 
usually do not survive to infancy. In surviving infants, severe neurological deficits, including 
generalized hypotonia, seizures, feeding problems and mental retardation become apparent 
since the early neonatal period. Abnormalities of the hypotalamic functions, such as diabetes 
insipidus and temperature instability are commonly associated with alobar HPE and may 
require emergency medical treatment, while other endocrine dysfunctions such as 
hypothyroidism, hypoadrenocorticism and growth hormone deficiency are less common39,40. 
In children with facial anomalies, impaired oromotor function may lead to aspiration 
syndrome, recurrent respiratory distress and chronic lung disease. In some cases, 
tracheostomy is needed to correct respiratory dysfunction.  Length of survival has been 
reported to be correlated with facial anomalies type, from few days in the most severe forms 
to 12-18 months in children with less severe facial anomalies41. Survival to adulthood has 
been rarely reported42,43. 
 
Children with less severe forms of HPE often survive neonatal period and may reach 
adulthood; in these cases, the most common causes of death include respiratory infections, 
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aspiration syndrome, dehydration secondary to uncontrolled diabetes insipidus, endocrine 
anomalies, failure of respiratory and control and heart rate, risk of aspiration, epilepsy and 
temperature instability39,44. Less severe of HPE form are characterized by mild to moderate 
mental retardation and about one-half of children with lobar HPE have normal or nearly 
motor function, while almost all have apparently normal vision and hearing39. Children with 
MIH variant of HPE typically have less severe motor and cognitive disabilities than do those 
with alobar or semilobar HPE; spasticity, hypotonia, dystonia, and motor development are the 
most common clinical symptoms affecting these children39. 
 
6. Pre- and post-natal management  
Once HPE is detected, prenatal invasive diagnosis, including CMA analysis, should be 
offered to parents in view of the high risk of chromosomal anomalies. Magnetic resonance 
imaging is usually not required in case of alobar HPE but can be useful in differentiating 
among semilobar, lobar and MIH variant HPE which are less commonly detected on 
ultrasound. Prenatal counselling should mention the high risk of recurrence in case of HPE 
not associated with chromosomal anomalies. In s small series 21 women with euploid 
holoprosencephaly, recurrence risk was 20%, thus highlighting the need for genetic parental 
analysis. Early first ultrasound assessment in the subsequent pregnancy should also be 
scheduled in these cases in order to detect recurrence45. In cases associated with 
chromosomal anomalies, risk of recurrence is about 1%.  
Post-natal management of children with HPE involves multiple medical treatments related to 
specific clinical symptoms. 
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SEPTO-OPTIC DYSPLASIA 
1. Definition and prevalence 
Septo-optic dysplasia (SOD), also known as de Morsier syndrome, is a rare disorder 
characterized by the presence of optic nerve hypoplasia, midline abnormalities, mainly ACC, 
and pituitary dysfunctions common leading to panhypopituitarism46-48. It is rather a spectrum 
of anomalies characterized by a peculiar clinical phenotype including optic nerve, midline 
and endocrine anomalies rather than a single clinical entity; anomalies of the cortical 
development, mainly schizencephaly, can co-exist within the classical clinical picture (SOD-
plus). 
Prevalence is about 1:100000 live-birth and most cases are sporadic with a recurrence risk 
<1%49-50.  
 
2. Etiology and pathophysiology  
Pathogenesis of SOD has not been completely elucidated yet although it has been proposed to 
be the results of mutation in HESX1, SOX1, SOX3, OTOX 2 e FGF8 genes, which play an 
essential role in the normal forebrain/pituitary development51. In particular, cases with SOX2 
mutations are associated with severe bilateral eye abnormalities, developmental delay, short 
stature, esophageal atresia, male genital tract abnormalities and sensorineural hearing loss46. 
Despite this, genetic abnormalities are identified in <1% of SOD. Viral infections, teratogens, 
such as valproic acid52 and maternal cocaine abuse have been also linked with sporadic forms 
of SOD53. 
 
3. Prenatal diagnosis  
Absent CSP and communicating frontal horns of the lateral ventricles, which gives a squared 
roof appearance, are the classical ultrasound signs of SOD.  However, these signs are not 
specific of SOD and can be encountered even in lobar HPE and isolated agenesis of the CSP 
54-56
.  
Interemispheric fissure is normal fissure is normal, while the corpus callosum may be present 
absent or hypoplastic; when present the course of the anterior cerebral arteries is normal. 
Fornices are not fused and thalami appear normal, mild ventriculomegaly can be also 
observed. Schizencephaly may be also observed (SOD-plus). Hypoplasia of the optic nerves 
and/or chiasma is fundamental in order to diagnose SOD; however, it cannot be easily 
detected on ultrasound or even MRI and may sometimes develop only after birth. Likewise, 
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pituitary hypoplasia cannot be detected on ultrasound and may lead to severe hormone 
deficiency only after birth. Facial anomalies such as hypotelorism, cleft lip and palate and flat 
nasal bridge are common in fetuses with SOD (Figure 3)56-57. 
Differential diagnosis between SOD and lobar HPE is not always feasible prenatally; the 
anterior part of interemispheric fissure is normal in SOD while it can be rudimentary in lobar 
HPE. CSP is absent and frontal horns are fused in either SOD and lobar HPE; however, SOD 
is characterized by squared appearance of the frontal horns with inferior pointing compared 
to the flat appearance observed in lobar HPE58. Fornices are normal in SOD while are fused 
in the midline creating an echogenic tick fascicle in the inferior part of the fused frontal horns 
in lobar HPE (Figure 3). Anomalies in maternal and fetal endocrine function may help in 
differentiating SOD form lobar HPE. Maternal urinary and serum estriol levels could be low 
in SOD while analysis of fetal cord blood could reveal fetal growth, adrenocorticotropic 
hormone (ACTH) and thyroid stimulating hormones deficiency57.  
In SOD, the optic tract can become abnormal only in the late third trimester or after birth; 
likewise, endocrine anomalies may not be evident before birth thus SOD cannot be 
completely rule out prenatally57. 
Fetal MRI can be useful to detect and quantify the degree of optical nerve and tract 
involvement, rule out schizencephaly and look associated supra and infra-tentorial anomalies. 
 
5. Prognosis  
Clinical presentation of children with SOD is highly variable and depends upon the presence 
of associated of associated anomalies, such as schizencephaly and ACC, and degree of 
pituitary involvement. Approximately 30% of SOD cases have complete manifestation of the 
clinical triad59. Ocular anomalies include nystagmus, blindness, inward and outward 
deviation of the eyes and micropthalmia. Optic nerve dysplasia has an early unset and is 
common bilateral (88% of cases)60-61. However, vision can be nearly normal in a small subset 
of affected cases. Neurological deficits range from focal epilepsy or hemiparesis to severe 
mental retardation62-63. Abnormal tone and seizures are common in case of SOD associated 
with schizencephaly.  
Furthermore, other neurological anomalies such as cerebellar hypoplasia, schizencephaly, 
aplasia of the fornix and cortical dysplasia can be present64. 
Signs of pituitary deficiency are present in 45% to 90% of affected cases and reange from 
isolated GH-deficit to severe panhypopituitarism65. 
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6. Pre- and post-natal management  
Fetuses suspected to be affected by SOD, on the basis of absent CSP and fused frontal horns, 
should undergo a detailed examination of cranial and extracranial structures in order to 
confirm the diagnosis and rule out associated anomalies. Invasive prenatal diagnosis, 
including CMA analysis, should be offered to rule out aneuploidy. MRI should be performed 
in order to detect signs of optic nerve involvement, although this may not be easily detected 
on MRI and can develop only after birth. Therefore, a follow-up MRI in the third trimester 
scan can be necessary also to rule out schizencephaly. Cordocentesis should be offered to 
look for signs of fetal hypopituitarism, although this may become evident only alter on in 
gestation or after birth. Prenatal counselling should stress the fact that SOD cannot be reliable 
ruled out prenatally even in fetuses not showing the classical ocular or endocrine anomalies 
of the disease. 
After birth, close follow-up by a multi-disciplinary team is needed in order to optimize 
hormonal replacements, ensuring ophthalmological care e neurodevelopmental support66-67.  
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ISOLATED AGENESIS OF THE CAVUM SEPTI PELLUCIDUM 
1. Definition and incidence 
CSP is an important landmark in the prenatal ultrasound evaluation of the fetal brain and is a 
marker for normal central forebrain development.  
CSP agenesis is a non-specific condition which may be congenital or acquired, isolated or 
associated with a large variety of CNS anomalies, including ACC, HPE, SOD and 
hydranencephaly, thus highlighting the need for a thorough examination of fetal brain with 
either ultrasound and MRI68. 
It is a rare disorder with an estimated incidence of 2 to 3 cases per 100 000 livebirths69. 
 
2. Prenatal diagnosis: ultrasound and MRI 
On ultrasound, septal agenesis presents with lack of visualization of CSP and a large 
communication between the frontal horns of the lateral ventricles (Figure 4). In the partial 
forms, frontal horns can be identified separately. Septal agenesis is not a specific condition 
with many midline anomalies presenting with lack of visualization of the CSP, such as lobar 
HPE and SOD. Therefore, a thorough examination of the midline structures should be 
performed in order to ascertain whether septal agenesis is isolated or associated with other 
major CNS anomalies.  Furthermore, in some CNS anomalies not involving the midline such 
as severe ventriculomegaly and hydranencephaly visualization of the CSP may be impaired 
by the accumulation of cerebrospinal fluid in the ventricular cavity and by the destructive 
process involving the midline respectively. 
Barkovich and Norman69 and Malinger et al54. have developed a diagnostic algorithm to 
apply in case of absent visualization of the CSP. Lack of visualization of the CSP should 
prompt a detailed assessment of the interemispheric fissure and frontal horns. If there is 
communication at the level of anterior portion of the lateral ventricles, possible diagnoses are 
alobar, semilobar or lobar HPE or SOD. Complete absence of interemispheric fissure, lack of 
distinct visualization of cerebral hemispheres and presence of a single ventricular cavity 
suggests alobar HPE, while presence of a posterior cleavage, fusion of the frontal horns and 
fornices is typical of lobar HPE. Anomalies of the optic nerves and tract, especially on MRI, 
normal anterior cleavage and downward pointing frontal horns suggests SOD. In case of 
separated anterior portion of the lateral ventricles, abnormal cleavage at the level of posterior 
frontal, parietal bones and basal ganglia suggest MIH variant of HPE, while a normal 
appearance should focus the attention on the presence of severe 
ventriculomegaly/hydranencephaly, cortical anomalies or an isolated agenesis of the CSP.  
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Serial follow-up scans during pregnancy are needed in order to elucidate whether agenesis is 
actually isolated as many anomalies, especially those involving neuronal migration processes, 
can be evident only in late gestation. Fetal MRI is needed to assess the optic nerves and tract 
and to rule out cortical anomalies. Despite this, a definitive diagnosis of isolated septal 
agenesis cannot be reliably performed prenatally as many anomalies may become apparent 
only after birth. 
 
3. Prognosis 
Prognosis of septal agenesis associated with other CNS anomalies is strictly dependent upon 
the type and severity of the anomaly.  
Despite its commonly reported association, failure to visualize the CSP during the second 
trimester may not always be associated with a CNS anomaly, but may represent a different 
condition with a peculiar clinical outcome. 
In a series of 16 fetuses with absent CSP, normal brain anatomy and a dedicated post-natal 
follow-up, normal development was reported in 14 children, one child had infantile hypotonia 
but normal developmental milestones while the other mild motor delay and language delay, 
thus suggesting that, when isolated, agenesis of CSP may be considered a variation of normal 
development and carry a relatively good prognosis70. Karyotype was normal in all cases. 
More importantly, complete septal agenesis seems to carry a better prognosis compared to 
partial. In a retrospective series of seventeen cases with either complete or partials septal 
agenesis, of the fourteen children with isolated complete SA, thirteen had normal 
neurological examination while one showed behavioural problems. Furthermore, none of 
them showed endocrine anomalies. Conversely, of the four children with a partial AS, two 
had a speech delay and visual-spatial dyspraxia. Similarly, none of the children with complete 
CSP agenesis had abnormal neuropsychological outcome compared to two with partial 
agenesis71. These findings, although affected by the small number of cases analysed, suggest 
that in most of the cases complete septal agenesis may represent a normal variant with 
relative good neurodevelopmental outcome, while partial agenesis a destructive process 
leading to a more generalized neurodevelopmental impairment.  
 
3. Pre and post-natal management  
Prenatal identification of apparently isolated septal agenesis should prompt a detailed 
assessment of fetal brain with either ultrasound and MRI. Invasive prenatal diagnosis should 
be offered to parents to rule out aneuploidy, while cordocentesis should be proposed to assess 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
the endocrine status of the fetus which may be altered in SOD.  Serial follow-up scans should 
be arranged in order to rule out anomalies which may become apparent only later on in 
gestation such as cortical malformations. MRI should be arranged to assess the optical nerves 
and tract, although this assessment may not always be feasible prenatally and reveal 
abnormalities only in late gestation or after birth. Parental counselling should stress the fact 
that a diagnosis of isolated agenesis of CSP cannot be reliably made prenatally in view of the 
high risk of associated anomalies which can become apparent only later on in gestation or 
after birth, that postnatal imaging and clinical examination is warranted in order to confirm 
the diagnosis.  
Post-natal management should include MRI, clinical and neuro-ophthalmic examination in 
order to rule out all the anomalies associated with septal agenesis such as SOD. Long term 
follow-up is needed to confirm diagnosis as some conditions, such as SOD, may become 
clinically evident only moths after birth.   
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Figure legend 
Figure 1. Anatomical representation of the different types of HPE. 
Figure 2. HPE in a fetus at 9 weeks of gestation. On ultrasound, alobar HPE is characterized 
by an absent interemispheric fissure, lack of visualization of two distinct cerebral 
hemispheres filled by the choroid plexus (“butterfly sign”) and presence of a single 
ventricular cavity communicating with a dorsal sac. Thalami are also fused in the midline. 
Figure 3. Coronal view of a fetus with normal brain anatomy (a), SOD (b) and lobar HPE (c). 
The anterior part of interemispheric fissure is normal in SOD while it can be rudimentary in 
lobar HPE. CSP is absent and frontal horns are fused in either SOD and lobar HPE; however, 
SOD is characterized by squared appearance of the frontal horns with inferior pointing 
compared to the flat appearance observed in lobar HPE (Figure 3b, arrows). Fornices are 
normal in SOD while are fused in the midline creating an echogenic tick fascicle in the 
inferior part of the fused frontal horns in lobar HPE (Figure c) (Courtesy of Professor. P. 
Volpe).  
Figure 4. Ultrasound axial (a) and coronal (b) views of a fetus affected by isolated septal 
agenesis. Forntal horns are fused in the midline, the anterior portion of the interemispheric 
fissure (a) and the corpus callosum (b) are present. (c) coronal view of the same fetus on MRI 
(Figures 7b and 7c courtesy of Professor T.Lerman-Sagie).  
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Fused frontal horns
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Alobar HPE Semilobar HPE Lobar HPE MIH Varinat 
 
 
Interemispheric 
fissure 
 
Absent 
 
Absent anteriorly 
 
Presence of some 
portions of posterior 
part 
 
 
Rudimentary in its 
anterior part 
 
Present posteriorly 
 
Present in the 
anterior frontal 
 
Absent in the 
posterior frontal and 
parietal regions 
 
 
 
Ventricles 
and 
Frontal Horns 
 
Single midline 
ventricular cavity 
communicating 
with a dorsal sac 
 
Rudimentary frontal 
horns 
 
Posterior horns are 
present 
 
Hypoplastic third 
ventricles 
 
 
Central fusion of the 
frontal horns, wich 
communicate with 
the third ventricle 
 
Frontal horns of the 
lateral ventricles can 
be normal or 
rudimentary but 
well separated 
 
In the median part 
the ventricles 
communicate 
 
 
CSP 
 
 
Absent 
 
Absent 
 
Absent 
 
Absent 
 
Dorsal sac 
 
 
Present (92%) 
 
Present (30%) 
 
Absent/dysplastic 
 
Absent 
 
Corpus Callosum 
 
Absent 
 
Rostrum, genu and 
body absent 
 
Splenium present 
 
Splenium present. 
 
Anterior body could 
be present 
 
Genu variably 
present 
 
Splenium present 
 
Body absent 
 
 
Thalami and basal 
ganglia 
 
 
 
Fused 
 
 
Partial fused 
 
 
Separated 
 
Incompletely 
separated in many 
patients 
 
Craniofacial 
anomalies 
 
 
 
Severe 
 
 
Variable 
 
 
Moderate/Absent 
 
 
Moderate/Absent 
 
